{"id":"https://openalex.org/W2162093563","doi":"https://doi.org/10.1002/bmc.1130090306","title":"Simultaneous determination of nadolol enantiomers in human plasma by high\u2010performance liquid chromatography using fluorescence\u2010detection","display_name":"Simultaneous determination of nadolol enantiomers in human plasma by high\u2010performance liquid chromatography using fluorescence\u2010detection","publication_year":1995,"publication_date":"1995-05-01","ids":{"openalex":"https://openalex.org/W2162093563","doi":"https://doi.org/10.1002/bmc.1130090306","mag":"2162093563","pmid":"https://pubmed.ncbi.nlm.nih.gov/7655302"},"language":"en","primary_location":{"id":"doi:10.1002/bmc.1130090306","doi":"https://doi.org/10.1002/bmc.1130090306","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bmc.1130090306","pdf_url":null,"source":{"id":"https://openalex.org/S123979729","display_name":"Biomedical Chromatography","issn_l":"0269-3879","issn":["0269-3879","1099-0801"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedical Chromatography","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066989770","display_name":"Frank J. Belas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank J. Belas","raw_affiliation_strings":["Department of Pharmacology (804 MRB), Vanderbilt University, Nashville, TN 37232-6602, USA","Department of Pharmacology (804 MRB), Vanderbilt University, 23rd Avenue South @ Pierce Avenue, Nashville, TN 37232-6602, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology (804 MRB), Vanderbilt University, Nashville, TN 37232-6602, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Department of Pharmacology (804 MRB), Vanderbilt University, 23rd Avenue South @ Pierce Avenue, Nashville, TN 37232-6602, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark A. Phillips","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Phillips","raw_affiliation_strings":["Department of Pharmacology (804 MRB), Vanderbilt University, 23rd Avenue South @ Pierce Avenue, Nashville, TN 37232-6602, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology (804 MRB), Vanderbilt University, 23rd Avenue South @ Pierce Avenue, Nashville, TN 37232-6602, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056704911","display_name":"Nuggehally R. Srinivas","orcid":"https://orcid.org/0000-0002-5768-1332","observed_orcids":["https://orcid.org/0000-0002-5768-1332"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nuggehally R. Srinivas","raw_affiliation_strings":["Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108807818","display_name":"Rashmi H. Barbhaiya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rashmi H. Barbhaiya","raw_affiliation_strings":["Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079384190","display_name":"Ian A. Blair","orcid":"https://orcid.org/0000-0003-0366-8658","observed_orcids":["https://orcid.org/0000-0003-0366-8658"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ian A. Blair","raw_affiliation_strings":["Department of Chemistry, Vanderbilt University, School of Medicine, Nashville, TN 37232, USA","Department of Pharmacology (804 MRB), Vanderbilt University, 23rd Avenue South @ Pierce Avenue, Nashville, TN 37232-6602, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Vanderbilt University, School of Medicine, Nashville, TN 37232, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Department of Pharmacology (804 MRB), Vanderbilt University, 23rd Avenue South @ Pierce Avenue, Nashville, TN 37232-6602, USA","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5079384190"],"corresponding_institution_ids":["https://openalex.org/I200719446"],"apc_list":{"value":3710,"currency":"USD","value_usd":3710},"apc_paid":null,"fwci":1.55,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.81712598,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"9","issue":"3","first_page":"140","last_page":"145"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nadolol","display_name":"nadolol","score":0.9829999804496765},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.968999981880188},{"id":"https://openalex.org/keywords/human-plasma","display_name":"human plasma","score":0.6209999918937683},{"id":"https://openalex.org/keywords/chiral-derivatization","display_name":"chiral derivatization","score":0.7160000205039978},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7239999771118164},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.6510000228881836},{"id":"https://openalex.org/keywords/enantiomeric-separation","display_name":"enantiomer separation","score":0.5360000133514404},{"id":"https://openalex.org/keywords/fluorescence-detection","display_name":"fluorescence detection","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C2776256041","wikidata":"https://www.wikidata.org/wiki/Q424952","display_name":"Nadolol","level":3,"score":0.9261910915374756},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9067642688751221},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.858127236366272},{"id":"https://openalex.org/C2776923573","wikidata":"https://www.wikidata.org/wiki/Q2294884","display_name":"Derivatization","level":3,"score":0.7990045547485352},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.7274781465530396},{"id":"https://openalex.org/C40875361","wikidata":"https://www.wikidata.org/wiki/Q2356542","display_name":"Reagent","level":2,"score":0.6269373297691345},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.6223631501197815},{"id":"https://openalex.org/C119128265","wikidata":"https://www.wikidata.org/wiki/Q900165","display_name":"Detection limit","level":2,"score":0.6063188314437866},{"id":"https://openalex.org/C3020134792","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Human plasma","level":2,"score":0.5272861123085022},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.46724581718444824},{"id":"https://openalex.org/C91881484","wikidata":"https://www.wikidata.org/wiki/Q191807","display_name":"Fluorescence","level":2,"score":0.4346825182437897},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.08760946989059448},{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.08244436979293823},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.07662075757980347},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.06560277938842773},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007202","descriptor_name":"Indicators and Reagents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009248","descriptor_name":"Nadolol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D009248","descriptor_name":"Nadolol","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012015","descriptor_name":"Reference Standards","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013050","descriptor_name":"Spectrometry, Fluorescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017953","descriptor_name":"Isocyanates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/bmc.1130090306","doi":"https://doi.org/10.1002/bmc.1130090306","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bmc.1130090306","pdf_url":null,"source":{"id":"https://openalex.org/S123979729","display_name":"Biomedical Chromatography","issn_l":"0269-3879","issn":["0269-3879","1099-0801"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedical Chromatography","raw_type":"journal-article"},{"id":"pmid:7655302","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7655302","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedical chromatography : BMC","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"study_designs":[],"awards":[{"id":"https://openalex.org/G120018185","display_name":null,"funder_award_id":"GM31304","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G2477595013","display_name":null,"funder_award_id":"GM-07569","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G7982882065","display_name":"DETERMINANTS  OF INDIVIDUAL RESPONSIVENESS TO DRUGS","funder_award_id":"P01GM031304","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G9000875921","display_name":"Clinical Pharmacology Training Program","funder_award_id":"T32GM007569","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W225421127","https://openalex.org/W1486744490","https://openalex.org/W1490309584","https://openalex.org/W1828356452","https://openalex.org/W1988238927","https://openalex.org/W1989044052","https://openalex.org/W1994232131","https://openalex.org/W2004401514","https://openalex.org/W2025880680","https://openalex.org/W2046908702","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2040118186","https://openalex.org/W3026914406","https://openalex.org/W2033958675","https://openalex.org/W2071422206","https://openalex.org/W2014396972","https://openalex.org/W2153467055","https://openalex.org/W2095512635","https://openalex.org/W1988238927","https://openalex.org/W2025880680","https://openalex.org/W2087947199"],"abstract_inverted_index":{"A":[0],"high-performance":[1],"liquid":[2],"chromatographic":[3],"assay":[4],"is":[5],"described":[6],"for":[7,72],"the":[8,31,46,58,84],"separation":[9],"and":[10,25,96],"quantification":[11],"of":[12,41,70,87],"nadolol":[13,42,88],"isomers":[14,19,89],"in":[15,90],"human":[16,91],"plasma.":[17],"The":[18,36,49,67],"were":[20],"quantified":[21],"using":[22],"reverse-phase":[23],"HPLC":[24],"fluorometric":[26],"detection":[27],"after":[28],"derivatization":[29],"with":[30],"chiral":[32],"reagent":[33],"R(-)-1-(naphthyl)ethylisocyanate":[34],"[R(-)-NEI].":[35],"N-isopropyl":[37],"analogue":[38],"(one":[39],"isomer)":[40],"was":[43,51,63,75,80],"used":[44,81],"as":[45],"internal":[47],"standard.":[48],"method":[50,79],"reproducible":[52],"based":[53],"on":[54],"precision":[55],"studies":[56],"where":[57],"percent":[59],"relatives":[60],"standard":[61],"deviation":[62],"less":[64],"than":[65],"15%.":[66],"lower":[68],"limit":[69],"quantitation":[71],"each":[73],"isomer":[74],"2.5":[76],"ng/mL.":[77],"This":[78],"to":[82],"evaluate":[83],"pharmacokinetic":[85],"profile":[86],"subjects":[92],"following":[93],"both":[94],"single":[95],"multiple":[97],"oral":[98],"dosing.":[99]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}